Infant Bacterial Therapeutics
Sanjiv Sharma is on the Board of Advisors at Infant Bacterial Therapeutics. Sanjiv has a blend of successful experience in large, mid-size, and start-up companies in North America and Asia, with national and global responsibility for companies like Sanofi and start-ups – NicOx and Duchesnay USA.
This person is not in the org chart
This person is not in any offices
Infant Bacterial Therapeutics
IBT is a clinical stage pharmaceutical company with a vision to develop drugs influencing the infant microbiome, and thereby prevent or treat rare diseases affecting infants.